| CAS No.: | Liraglutide |
|---|---|
| Formula: | C172h265n43o51 |
| EINECS: | Victoza |
| Type: | Pharmaceutical Intermediates |
| Appearance: | Powder |
| Quality: | Technical |
| Samples: |
|---|
| Customization: |
|---|
Suppliers with verified business licenses
Audited Supplier 
Product Information
Products Name: Liraglutide
Trade Name: Victoza
Purity: >98.0%
Molecular Formula:C172H265N43O51
Molecular Weight: 3751.202g/mol
Sequence: H-His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys(γ-Glu-palmitoyl)-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-Arg-Gly-OH
Appearance: White Lyophilized powder
Reconstitution: Required
Storage:After reconstitution store at 2°C - 8°C
Description:
WHAT IS Liraglutide?
FDA is approving Victoza (liraglutide), a once-daily injection to treat type 2 diabetes mellitus (T2DM) in adults. Victoza is intended to help lower blood sugar (glucose) levels, along with diet and exercise. Controlling elevated blood sugar levels is important in preventing complications of diabetes, such as kidney disease and blindness.
People with T2DM have difficulty making and using insuli, a hormone that helps prevent glucose from building up in the blood. Victoza works by helping the pancreas release more insuli after eating a meal.
Although there are many anti-diabetic medications already available for use, often people with T2DM will require different or additional anti-diabetic medications to control their blood sugar, given the chronic nature of this disease. Therefore, Victoza is another medication that can be used to help control blood sugar, but it is not recommended as first-line therapy for patients whose blood sugar is not controlled through diet and exercise.
Suppliers with verified business licenses
Audited Supplier 
){kind=link}
){kind=link}